Thoratec drops sale of subsidiary to Danaher

07/27/2010 | American City Business Journals

Thoratec has terminated the sale of International Technidyne, which manufactures point-of-care blood tests and skin incision products, to Danaher for $110 million because of disagreements on "certain aspects of ITC's quality system and regulatory filings." Thoratec said it will consider the unit as "held for sale" for its financial results despite the cancellation of the deal.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ